Key result
Leadless pacemakers are preferred for older patients with comorbidities due to a reported 63% reduction in major complications compared to traditional transvenous systems.
No takes yet. Share an insight, caveat, or question.
May support Micra preference in high-risk patients; leaves open comparative long-term data versus transvenous systems.
Ogano et al. (2022) studied Ventricular pacing. Leadless pacemaker (Micra) vs. Traditional transvenous pacing systems was evaluated. Leadless pacemakers are preferred for older patients with comorbidities due to a reported 63% reduction in major complications compared to traditional transvenous systems.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: